Retatrutide vs Tirzepatide: 89-Week Obesity Study Underway | Retatrutide News

A clinical trial is comparing retatrutide and tirzepatide for obesity treatment over 89 weeks. The study is active but not recruiting, focusing on effic...
Clinical Trials · October 22, 2026